We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
-2.51%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$187M
AUM Growth
-$7.37M
Cap. Flow
-$1.13M
Cap. Flow %
-0.6%
Top 10 Hldgs %
57.44%
Holding
56
New
–
Increased
11
Reduced
43
Closed
2

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.39M
2
UPS icon
United Parcel Service
UPS
+$749K
3
GILD icon
Gilead Sciences
GILD
+$659K
4
NVO
Novo Nordisk
NVO
+$529K
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$404K

Top Sells

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$755K
2
WFC icon
Wells Fargo
WFC
+$611K
3
JNJ icon
Johnson & Johnson
JNJ
+$470K
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$330K
5
JPM icon
JPMorgan Chase
JPM
+$312K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.61%
2 Financials 13.63%
3 Healthcare 10.97%
4 Technology 8.62%
5 Industrials 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
1
Home Depot
HD
$332B
$63.6M 33.98%
163,413
-210
-0.1% -$85.8K
JPM icon
2
JPMorgan Chase
JPM
$933B
$5.49M 2.94%
22,910
-1,341
-6% -$312K
WFC icon
3
Wells Fargo
WFC
$258B
$5.46M 2.92%
77,730
-8,954
-10% -$611K
AJG icon
4
Arthur J. Gallagher & Co
AJG
$65.9B
$5.18M 2.77%
18,232
-2,596
-12% -$755K
MSFT icon
5
Microsoft
MSFT
$3.35T
$4.81M 2.57%
11,416
-107
-0.9% -$45.6K
ABT icon
6
Abbott
ABT
$183B
$4.76M 2.54%
42,081
-548
-1% -$63.3K
HON icon
7
Honeywell
HON
$76.7B
$4.73M 2.53%
22,236
-462
-2% -$96.3K
GILD icon
8
Gilead Sciences
GILD
$163B
$4.72M 2.52%
51,083
+7,322
+17% +$659K
MCD icon
9
McDonald's
MCD
$191B
$4.42M 2.36%
15,248
-359
-2% -$107K
PG icon
10
Procter & Gamble
PG
$335B
$4.33M 2.31%
25,821
-214
-0.8% -$36.4K
ACN icon
11
Accenture
ACN
$99.9B
$4.21M 2.25%
11,970
-38
-0.3% -$13.7K
LHX icon
12
L3Harris
LHX
$50.7B
$4.07M 2.17%
19,347
-369
-2% -$88.4K
SHEL icon
13
Shell
SHEL
$250B
$4M 2.14%
63,915
-445
-0.7% -$29.2K
NVO
14
Novo Nordisk
NVO
$228B
$3.81M 2.04%
44,309
+4,896
+12% +$529K
DD icon
15
DuPont de Nemours
DD
$18.7B
$3.75M 2%
39,139
-494
-1% -$51.4K
CMCSA icon
16
Comcast
CMCSA
$84B
$3.67M 1.96%
97,829
-1,004
-1% -$41.7K
AZN icon
17
AstraZeneca
AZN
$266B
$3.67M 1.96%
27,993
+9,914
+55% +$1.39M
USB icon
18
US Bancorp
USB
$98B
$3.52M 1.88%
73,697
-3,756
-5% -$185K
UPS icon
19
United Parcel Service
UPS
$89.5B
$3.43M 1.83%
27,167
+5,691
+26% +$749K
BAC icon
20
Bank of America
BAC
$433B
$3.19M 1.7%
72,531
-2,633
-4% -$116K
CVX icon
21
Chevron
CVX
$383B
$3.16M 1.69%
21,806
-30
-0.1% -$4.59K
ADI icon
22
Analog Devices
ADI
$179B
$3.13M 1.67%
14,735
-189
-1% -$41.8K
EQIX icon
23
Equinix
EQIX
$103B
$3.12M 1.67%
3,309
-43
-1% -$39.6K
COP icon
24
ConocoPhillips
COP
$145B
$2.91M 1.55%
29,325
-1,693
-5% -$180K
PNC icon
25
PNC Financial Services
PNC
$99.2B
$2.67M 1.43%
13,836
-119
-0.9% -$23.4K
1
2 3

Similar funds

SEP
Signature Equity Partners Columbus, Ohio $186M AUM
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BGA
Battery Global Advisors Boston, Massachusetts $186M AUM 15.74% 1-Year Est. Return
OBC
Oakum Bay Capital Westport, Connecticut $187M AUM
LPCM
Lynwood Price Capital Management Austin, Texas $186M AUM 5.63% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
AC
AMANSA Capital Raffles City Tower, Singapore $187M AUM 38.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $187M AUM 18.9% 1-Year Est. Return

Brookmont Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Brookmont Capital Management held 56 positions worth $187M, down 3.8% from $194M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.6%. Brookmont Capital Management opened no new positions and exited 2, leaving the 56-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.

  • Brookmont Capital Management added most to AstraZeneca in Q4 2024, an estimated $1.39M increase.
  • Brookmont Capital Management's biggest Q4 2024 reduction was Arthur J. Gallagher & Co, cutting an estimated $755K.
  • Brookmont Capital Management fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $273K.
  • Brookmont Capital Management's ten largest holdings make up 57% of its $187M portfolio in Q4 2024.
  • Brookmont Capital Management opened 0 new positions and closed 2 in Q4 2024.
  • Brookmont Capital Management's portfolio value fell 3.8% quarter-over-quarter to $187M.

Based on Brookmont Capital Management's 13F filing for Q4 2024, filed 16 Jan 2025.